Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05226585 · ClinicalTrials.gov registry record · NA
Mechanisms of Change in Cognitive Behavioral Therapy for Insomnia (CBTi)
A NA study, sponsored by University of Arizona.
- Completed
- Registry status
- NA
- Development phase
- 93
- Enrollment target
NCT05226585: Completed NA study, sponsored by University of Arizona.
NCT05226585 is a NA study that has completed, run by University of Arizona. The registered enrollment target is 93 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05226585, a NA study, has completed, sponsored by University of Arizona.
- COMPLETED
- Registry status
- NA
- Development phase
- 93 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the mechanisms of change in Cognitive Behavioral Therapy for insomnia (CBTi) in a sample of adults aged 50-65. This study aims to evaluate the pre-post treatment change in sleep, circadian rhythms, biomarkers, cognitive performance, and structural and functional magnetic resonance imaging scans (MRI).
Primary Outcome
Self-reported severity of insomnia symptoms is assessed once at baseline.
Interventions
- BEHAVIORAL In-Person Cognitive Behavioral Therapy for Insomnia
- BEHAVIORAL Telehealth Cognitive Behavioral Therapy for Insomnia
- BEHAVIORAL Internet Cognitive Behavioral Therapy for Insomnia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 93 participants |
| Start Date | 2021-09-26 |
| Est. Completion | 2024-12-17 |
| Phase | NA |
What the finished NCT05226585 record still lists
NCT05226585 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 93 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 3 interventions - of which In-Person Cognitive Behavioral Therapy for Insomnia is the first listed.
NCT05226585 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05226585 about?
NCT05226585 is a clinical study titled "Mechanisms of Change in Cognitive Behavioral Therapy for Insomnia (CBTi)". The purpose of this study is to investigate the mechanisms of change in Cognitive Behavioral Therapy for insomnia (CBTi) in a sample of adults aged 50-65. This study aims to evaluate the pre-post treatment change in sleep, circadian rhythms, biomarkers, cognitive performance, and structural and func...
What is the current status of trial NCT05226585?
This trial is currently completed. It is a NA study. The enrollment target is 93 participants. The study started on 2021-09-26. Estimated completion is 2024-12-17.
What interventions are being tested in trial NCT05226585?
The interventions under investigation include: In-Person Cognitive Behavioral Therapy for Insomnia (BEHAVIORAL), Telehealth Cognitive Behavioral Therapy for Insomnia (BEHAVIORAL), Internet Cognitive Behavioral Therapy for Insomnia (BEHAVIORAL).
Who is sponsoring clinical trial NCT05226585?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05226585's enrollment target sits among peer trials
93 937th of 2000 higher than 1,064 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02203526 · 93 participants · Phase 1
Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (TEDDI-R) in Primary CNS Lymphoma
- NCT03089554 · 93 participants · Phase 2
Evaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies
- NCT05000021 · 93 participants · NA
Reducing Diabetes Distress Using Cognitive Behavioral Therapy in Young Adults With Type 1 Diabetes
- NCT05489887 · 93 participants · Phase 2
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI